0.10Open0.10Pre Close0 Volume214 Open Interest2.50Strike Price0.00Turnover418.63%IV261.11%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier28DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.3092Delta0.4239Gamma7.20Leverage Ratio-0.0053Theta0.0001Rho2.23Eff Leverage0.0007Vega
Ocean Biomedical Stock Discussion
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses
Ocean Biomedical's Anti-CHI3L1 patent coverage includes multiple methods of use for targeting a broad range of Cancers that include Lung Cancer, Glioblastoma, Prostate Cancer, Melanoma, and Breast Cancer
Providence, RI, Oct. 01...
No comment yet